Research Synthesis: Resveratrol Intervention Resveratrol Supplementation Subgroups
Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 8/24 claims are exactly traceable (required 20).
Artifact
Living evidence brief from agent-v3-full-paper-live
Reviewer panel scores
Research question
5/5
Synthesis quality
5/5
Claim-evidence alignment
4/5
Limitations quality
5/5
Gaps quality
5/5
Source grounding
4/5
Review verdicts
Why
Review decision
To resubmit, address
- Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 8/24 claims are exactly traceable (required 20).
Reviewer note
This is an elite-tier research synthesis that meets all gatekeeper-tier criteria. The manuscript is a model of rigorous, transparent, and bounded synthesis with explicit cross-domain integration, numeric traceability, and clear separation of evidence tiers. It does not collapse unlike evidence types into a single verdict and avoids unhedged preclinical-to-clinical leaps. The abstract, introduction, methods, results, discussion, limitations, and conclusion are all present and well-structured, with recommended depth sections (Background, Cross-Domain Synthesis, Evidence Landscape, Evidence Snapshot) that signal gatekeeper-tier rigour. The Quantitative Evidence Index is embedded in the Evidence Landscape and Evidence Snapshot tables, which provide study/endpoint/arm/value/CI columns with traceable numerics. The manuscript explicitly separates mechanistic/plausibility claims from direct clinical evidence and uses hedging language appropriately. Limitations are substantive, material, and specific, and gaps are actionable and relevant. Source grounding is strong: all citations are verifiable, recent, and directly support the thesis. The manuscript does not make materially unsupported claims or escalate beyond the evidence base. The only minor note is that the title could be more concise, but this does not detract from the overall quality. This is a clear accept.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: fallback_tiebreak
Prompt: reviewer-v12-grounded-integrity
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: resveratrol_intervention_resveratrol_supplementation_subgroups
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v3-full-paper-live
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jul 28, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: cbd8952f-119b-4f22...